Repligen Corp (RGEN)
$150.35
Repligen Corp (RGEN) Share Price Forecast
Currently 19 wall-street analysts regularly analyze the financials of Repligen Corp on a frequent basis to provide recommendations along with target share price. 19 analysts offering 12-month price forecasts for Repligen Corp (RGEN) have a share price target of $204.58. This median of share price forecast represents a 36.07% upside from the latest price of $150.35 as on 04.06.24.
Repligen Corp (RGEN) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Repligen Corp (RGEN) share price will touch around $204.58 in next 12-months.
Repligen Corp (RGEN) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Repligen Corp's share price and its median forecast price. As on 04.06.24, the difference is -22.59%
Repligen Corp (RGEN): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Repligen Corp (RGEN) Share Price : Analyst Recommendation
Based on 19 analysts tracking and researching Repligen Corp (RGEN) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 9 | 9 | 9 |
| Outperform | 6 | 6 | 6 |
| Hold | 4 | 4 | 4 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Repligen Corp (RGEN) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Repligen Corp (RGEN) is $204.58, offered by 19 analysts offering 12-month price forecasts.
Repligen Corp (RGEN) has a maximum of 0.36 upside potential, based on 19 analysts offering 12-month price forecasts.
Based on 19 analysts tracking and researching Repligen Corp (RGEN), 78.95% have a buy recommendation. Remaining 21.05% have either sell or hold recommendations.
The latest share price of Repligen Corp (RGEN) is $150.35 as of 04/06/2024.
15 of total 19 analysts offering stock ratings for Repligen Corp RGEN have recommended buy rating.
₹0 US Stocks a/c Opening Fee